Zyrtec-D Tablets from Single GSK Malaysia Batch Recalled
GlaxoSmithKline Malaysia (GSK) has recalled its Zyrtec-D Allergy Relief and Nasal Decongestant Tablets, batch number 321907, containing 120mg/5mg Tablets x400, due to incorrect blister sealing. In a statement released on Thursday, GSK announced that the recall is a precautionary measure and affects all tablet packs and/or blisters from this batch, including those already dispensed to patients.
GSK has requested patients who have been dispensed Zyrtec-D tablets from any in-country retail, pharmacy, or healthcare outlet to return the product to the original point of purchase immediately, within the next 15 days. Healthcare professionals have also been advised to cease prescribing, dispensing, selling, or distributing products from this batch, and patients are encouraged to seek alternative treatments from their healthcare provider.
[the_ad id=”10542″]
The company confirmed that no other complaints have been received regarding this product since 2018, and there is no evidence that any other batches are affected. GSK has also clarified that the recall does not affect Zyrtec Drop 10mg/ml, Zyrtec Solution 1mg/ml, and Zyrtec Tablet 10mg.
Consumers or healthcare providers with any questions regarding this recall can contact GSK via phone at +603-7495 2600 or email at my.corporatecommunications@gsk.com during office hours. Patients who have been prescribed and dispensed products from this batch and have concerns are advised to contact their healthcare provider first.
[the_ad id=”10542″]
Pharmacies, clinics, and hospitals that have recalled products to be returned can contact Zuellig Pharma Sdn Bhd at 1-800 88 1388 or email csc@zuelligpharma.com. Any matter related to human safety information or adverse events can be reported to GSK Pharmacovigilance via email at drugsafetyinfo.my@gsk.com.
The recall highlights the importance of maintaining quality control and ensuring product safety. GSK’s prompt action is expected to minimise potential health risks and protect consumers’ well-being.
[the_ad id=”10542″]
